open access

Vol 86, No 6 (2018)
ORIGINAL PAPERS
Published online: 2018-12-30
Submitted: 2018-10-12
Accepted: 2018-12-02
Get Citation

Speech therapy in the management of difficult-to-treat chronic cough — preliminary results

Marta Dąbrowska, Elżbieta Magdalena Grabczak, Dorota Rojek, Anna Łobacz, Karolina Klimowicz, Olga Truba, Aleksandra Rybka, Antoni Krzeski, Rafał Krenke
DOI: 10.5603/ARM.a2018.0044
·
Pubmed: 30594993
·
Adv Respir Med 2018;86(6):268-274.

open access

Vol 86, No 6 (2018)
ORIGINAL PAPERS
Published online: 2018-12-30
Submitted: 2018-10-12
Accepted: 2018-12-02

Abstract

Introduction: The efficacy of management of chronic cough in adults is limited. Speech therapy is one of the few therapeutic
methods which seems to be useful in patients with persistent chronic cough. However, the method has not been available in
Poland so far. The aim of the study was to implement speech therapy and assess its efficacy in the management of patients with
difficult-to-treat chronic cough.

Material and methods: Patients, who were diagnosed and managed due to difficult-to-treat chronic cough, were enrolled into
the study. Speech therapy was developed on the basis of the technique described by Vertigan. The entire therapy consisted of
eight weekly sessions, each lasting 45 minutes. Before and after speech therapy, cough severity and its impact on the quality of
life was assessed by the Visual Analogue Scale (VAS) and Leicester Cough Questionnaire (LCQ). Additionally, cough challenge
test with capsaicin was performed.

Results: Eighteen women were enrolled into the study, 15 of them (83%) attended all treatment sessions (median age 66 years,
median duration of cough 60 months). There was a significant decrease in cough severity measured by VAS (46 vs 28 mm, p =
0.016) after completion of speech therapy. A significant improvement in patients’ quality of life measured by LCQ (10.7 vs 14.6
points, p = 0.004) and an increase in the threshold of cough reflex measured by capsaicin challenge were also demonstrated.

Conclusions: Speech therapy resulted in a decrease in cough severity and improvement of quality of life of females with refractory
chronic cough. Our results support the use of speech therapy as add-on treatment in females with difficult-to-treat cough.

Abstract

Introduction: The efficacy of management of chronic cough in adults is limited. Speech therapy is one of the few therapeutic
methods which seems to be useful in patients with persistent chronic cough. However, the method has not been available in
Poland so far. The aim of the study was to implement speech therapy and assess its efficacy in the management of patients with
difficult-to-treat chronic cough.

Material and methods: Patients, who were diagnosed and managed due to difficult-to-treat chronic cough, were enrolled into
the study. Speech therapy was developed on the basis of the technique described by Vertigan. The entire therapy consisted of
eight weekly sessions, each lasting 45 minutes. Before and after speech therapy, cough severity and its impact on the quality of
life was assessed by the Visual Analogue Scale (VAS) and Leicester Cough Questionnaire (LCQ). Additionally, cough challenge
test with capsaicin was performed.

Results: Eighteen women were enrolled into the study, 15 of them (83%) attended all treatment sessions (median age 66 years,
median duration of cough 60 months). There was a significant decrease in cough severity measured by VAS (46 vs 28 mm, p =
0.016) after completion of speech therapy. A significant improvement in patients’ quality of life measured by LCQ (10.7 vs 14.6
points, p = 0.004) and an increase in the threshold of cough reflex measured by capsaicin challenge were also demonstrated.

Conclusions: Speech therapy resulted in a decrease in cough severity and improvement of quality of life of females with refractory
chronic cough. Our results support the use of speech therapy as add-on treatment in females with difficult-to-treat cough.

Get Citation

Keywords

chronic cough, cough management, difficult-to-treat cough, speech therapy

About this article
Title

Speech therapy in the management of difficult-to-treat chronic cough — preliminary results

Journal

Advances in Respiratory Medicine

Issue

Vol 86, No 6 (2018)

Pages

268-274

Published online

2018-12-30

DOI

10.5603/ARM.a2018.0044

Pubmed

30594993

Bibliographic record

Adv Respir Med 2018;86(6):268-274.

Keywords

chronic cough
cough management
difficult-to-treat cough
speech therapy

Authors

Marta Dąbrowska
Elżbieta Magdalena Grabczak
Dorota Rojek
Anna Łobacz
Karolina Klimowicz
Olga Truba
Aleksandra Rybka
Antoni Krzeski
Rafał Krenke

References (25)
  1. Morice AH, McGarvey L, Pavord I, et al. British Thoracic Society Cough Guideline Group. Recommendations for the management of cough in adults. Thorax. 2006; 61 Suppl 1: i1–24.
  2. Irwin RS, Baumann MH, Bolser DC, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 Suppl): 1S–23S.
  3. Morice AH, Fontana GA, Sovijarvi ARA, et al. ERS Task Force. The diagnosis and management of chronic cough. Eur Respir J. 2004; 24(3): 481–492.
  4. Chamberlain SAF, Garrod R, Douiri A, et al. The impact of chronic cough: a cross-sectional European survey. Lung. 2015; 193(3): 401–408.
  5. Polakowska M, Kaleta D, Piotrowski W, et al. Tobacco smoking in Poland in the years from 2003 to 2014. Multi‑centre National Population Health Examination Survey (WOBASZ). Pol Arch Intern Med. 2017; 127(2): 91–99.
  6. Dąbrowska M, Grabczak EM, Arcimowicz M, et al. Causes of Chronic Cough in Non-smoking Patients. Adv Exp Med Biol. 2015; 873: 25–33.
  7. Gibson P, Wang G, McGarvey L, et al. CHEST Expert Cough Panel, CHEST Expert Cough Panel. Treatment of unexplained chronic cough: Chest guideline and expert panel report. Chest. 2016; 149(1): 27–44.
  8. Polley L, Yaman N, Heaney L, et al. Impact of cough across different chronic respiratory diseases: comparison of two cough-specific health-related quality of life questionnaires. Chest. 2008; 134(2): 295–302.
  9. French CT, Irwin RS, Curley FJ, et al. Impact of chronic cough on quality of life. Arch Intern Med. 1998; 158: 1657–1661.
  10. Chamberlain S, Birring SS, Garrod R. Nonpharmacological interventions for refractory chronic cough patients: systematic review. Lung. 2014; 192(1): 75–85.
  11. Gibson PG, Vertigan AE. Speech pathology for chronic cough: a new approach. Pulm Pharmacol Ther. 2009; 22(2): 159–162.
  12. Vertigan AE, Theodoros DG, Gibson PG, et al. Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax. 2006; 61(12): 1065–1069.
  13. Vertigan AE, Kapela SL, Ryan NM, et al. Pregabalin and Speech Pathology Combination Therapy for Refractory Chronic Cough: A Randomized Controlled Trial. Chest. 2016; 149(3): 639–648.
  14. Chamberlain Mitchell SAF, Garrod R, Clark L, et al. Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial. Thorax. 2017; 72(2): 129–136.
  15. Vertigan AE, Theodoros DG, Winkworth AL, et al. Chronic cough: a tutorial for speech-language pathologists. J Med Speech Lang Pathol. 2007; 15: 189–206.
  16. Dąbrowska M, Krakowiak K, Radlińska O, et al. Validation of the Polish Version of the Chronic Cough Quality of Life Questionnaire (Leicester Cough Questionnaire). Adv Clin Exp Med. 2016; 25(4): 649–653.
  17. Morice AH, Fontana GA, Belvisi MG, et al. European Respiratory Society (ERS). ERS guidelines on the assessment of cough. Eur Respir J. 2007; 29(6): 1256–1276.
  18. Boulet LP, Coeytaux RR, McCrory DC, et al. CHEST Expert Cough Panel. Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report. Chest. 2015; 147(3): 804–814.
  19. Spinou A, Birring SS. An update on measurement and monitoring of cough: what are the important study endpoints? J Thorac Dis. 2014; 6(Suppl 7): S728–S734.
  20. Morice AH, Millqvist E, Belvisi MG, et al. Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J. 2014; 44(5): 1132–1148.
  21. Haque RA, Usmani OS, Barnes PJ. Chronic idiopathic cough: a discrete clinical entity? Chest. 2005; 127(5): 1710–1713.
  22. Birring SS. New concepts in the management of chronic cough. Pulm Pharmacol Ther. 2011; 24(3): 334–338.
  23. Patel AS, Watkin G, Willig B, et al. Improvement in health status following cough-suppression physiotherapy for patients with chronic cough. Chron Respir Dis. 2011; 8(4): 253–258.
  24. Ryan NM, Vertigan AE, Bone S, et al. Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough. Cough. 2010; 6: 5.
  25. Krakowiak K, Dąbrowska M, Buła F, et al. Speech therapy - a non-pharmacological method to manage difficult-to-treat chronic cough. Adv Respir Med. 2017; 85(2): 116–120.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl